serw-MX  [xml]  
 


    
 Categorias DeCS

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10.228.140.163.100 Brain Diseases, Metabolic, Inborn .
C10.228.140.163.100.435 Lysosomal Storage Diseases, Nervous System .
C10.228.140.163.100.435.825 Sphingolipidoses .
C10.228.140.163.100.435.825.300 Gangliosidoses .
C10.228.140.163.100.435.825.300.300 Gangliosidoses, GM2 .
C10.228.140.163.100.435.825.300.300.500 Tay-Sachs Disease .
C10.228.140.163.100.435.825.300.300.750 Tay-Sachs Disease, AB Variant .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.435 Lysosomal Storage Diseases, Nervous System .
C16.320.565.189.435.825 Sphingolipidoses .
C16.320.565.189.435.825.300 Gangliosidoses .
C16.320.565.189.435.825.300.300 Gangliosidoses, GM2 .
C16.320.565.189.435.825.300.300.500 Tay-Sachs Disease .
C16.320.565.189.435.825.300.300.750 Tay-Sachs Disease, AB Variant .
C16.320.565.398 Lipid Metabolism, Inborn Errors .
C16.320.565.398.641 Lipidoses .
C16.320.565.398.641.803 Sphingolipidoses .
C16.320.565.398.641.803.350 Gangliosidoses .
C16.320.565.398.641.803.350.300 Gangliosidoses, GM2 .
C16.320.565.398.641.803.350.300.850 Tay-Sachs Disease .
C16.320.565.398.641.803.350.300.925 Tay-Sachs Disease, AB Variant .
C16.320.565.595 Lysosomal Storage Diseases .
C16.320.565.595.554 Lysosomal Storage Diseases, Nervous System .
C16.320.565.595.554.825 Sphingolipidoses .
C16.320.565.595.554.825.300 Gangliosidoses .
C16.320.565.595.554.825.300.300 Gangliosidoses, GM2 .
C16.320.565.595.554.825.300.300.840 Tay-Sachs Disease .
C16.320.565.595.554.825.300.300.920 Tay-Sachs Disease, AB Variant .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.435 Lysosomal Storage Diseases, Nervous System .
C18.452.132.100.435.825 Sphingolipidoses .
C18.452.132.100.435.825.300 Gangliosidoses .
C18.452.132.100.435.825.300.300 Gangliosidoses, GM2 .
C18.452.132.100.435.825.300.300.500 Tay-Sachs Disease .
C18.452.132.100.435.825.300.300.750 Tay-Sachs Disease, AB Variant .
C18.452.584 Lipid Metabolism Disorders .
C18.452.584.687 Lipidoses .
C18.452.584.687.803 Sphingolipidoses .
C18.452.584.687.803.350 Gangliosidoses .
C18.452.584.687.803.350.300 Gangliosidoses, GM2 .
C18.452.584.687.803.350.300.850 Tay-Sachs Disease .
C18.452.584.687.803.350.300.925 Tay-Sachs Disease, AB Variant .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.435 Lysosomal Storage Diseases, Nervous System .
C18.452.648.189.435.825 Sphingolipidoses .
C18.452.648.189.435.825.300 Gangliosidoses .
C18.452.648.189.435.825.300.300 Gangliosidoses, GM2 .
C18.452.648.189.435.825.300.300.500 Tay-Sachs Disease .
C18.452.648.189.435.825.300.300.750 Tay-Sachs Disease, AB Variant .
C18.452.648.398 Lipid Metabolism, Inborn Errors .
C18.452.648.398.641 Lipidoses .
C18.452.648.398.641.803 Sphingolipidoses .
C18.452.648.398.641.803.350 Gangliosidoses .
C18.452.648.398.641.803.350.300 Gangliosidoses, GM2 .
C18.452.648.398.641.803.350.300.850 Tay-Sachs Disease .
C18.452.648.398.641.803.350.300.925 Tay-Sachs Disease, AB Variant .
C18.452.648.595 Lysosomal Storage Diseases .
C18.452.648.595.554 Lysosomal Storage Diseases, Nervous System .
C18.452.648.595.554.825 Sphingolipidoses .
C18.452.648.595.554.825.300 Gangliosidoses .
C18.452.648.595.554.825.300.300 Gangliosidoses, GM2 .
C18.452.648.595.554.825.300.300.840 Tay-Sachs Disease .
C18.452.648.595.554.825.300.300.920 Tay-Sachs Disease, AB Variant .
D09 Carbohydrates .
D09.400 Glycoconjugates .
D09.400.410 Glycolipids .
D09.400.410.420 Glycosphingolipids .
D09.400.410.420.025 Acidic Glycosphingolipids .
D09.400.410.420.025.475 Gangliosides .
D09.400.410.420.025.475.400 G(M2) Ganglioside .
D10 Lipids .
D10.390 Glycolipids .
D10.390.470 Glycosphingolipids .
D10.390.470.025 Acidic Glycosphingolipids .
D10.390.470.025.475 Gangliosides .
D10.390.470.025.475.400 G(M2) Ganglioside .
D10.570 Membrane Lipids .
D10.570.877 Sphingolipids .
D10.570.877.360 Glycosphingolipids .
D10.570.877.360.025 Acidic Glycosphingolipids .
D10.570.877.360.025.475 Gangliosides .
D10.570.877.360.025.475.400 G(M2) Ganglioside .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Tay-Sachs Disease .
Amaurotic Familial Idiocy .
B Variant GM2 Gangliosidosis .
B Variant GM2-Gangliosidosis .
Deficiency Disease Hexosaminidase A .
Familial Amaurotic Idiocy .
GM2 Gangliosidosis, B Variant .
GM2 Gangliosidosis, Type 1 .
GM2 Gangliosidosis, Type I .
GM2-Gangliosidosis, Type I .
Gangliosidosis GM2 , Type 1 .
Gangliosidosis GM2, Type I .
HexA Deficiency .
Hexosaminidase A Deficiency .
Hexosaminidase alpha-Subunit Deficiency (Variant B) .
Sphingolipidosis, Tay-Sachs .
Amaurotic Idiocy, Familial .
B Variant GM2-Gangliosidoses .
Deficiency, Hexosaminidase A .
Deficiency, Hexosaminidase alpha-Subunit (Variant B) .
GM2-Gangliosidosis, B Variant .
Hexosaminidase alpha Subunit Deficiency (Variant B) .
Sphingolipidosis, Tay Sachs .
Tay Sachs Disease .
Tay Sachs Disease, B Variant .
Tay-Sachs Sphingolipidosis .
Type I GM2-Gangliosidosis .
Gangliosidosis G(M2), Type I .
G(M2) Gangliosidosis, Type I .
Gangliosidosis GM2, B Variant .
Hexosaminidase A Deficiency Disease .
Tay-Sachs Disease, B Variant .
Amaurotic Familial Idiocy .
Gangliosidosis GM2, Type I .
1.00
13918
 
G(M2) Ganglioside .
Ganglioside GM2 .
GM2, Ganglioside .
Ganglioside, Tay-Sachs Disease .
Tay Sachs Disease Ganglioside .
Tay-Sachs Disease Ganglioside .
0.78
1692
 
Tay-Sachs Disease, AB Variant .
AB Variant GM2-Gangliosidosis .
AB Variant Gangliosidosis GM2 .
Activator Deficiency GM2 Gangliosidosis .
Activator-Deficient Tay-Sachs Disease .
Deficiency Disease, GM2 Protein Activator .
GM2 Activator Deficiency .
GM2 Activator Deficiency Disease .
GM2 Gangliosidosis, Type AB .
GM2-Gangliosidosis, AB Variant .
Hexosaminidase Activator Deficiency .
Hexosaminidase Activator Protein Deficiency Disease .
AB Variant GM2 Gangliosidosis .
AB Variant GM2-Gangliosidoses .
Activator Deficiencies, GM2 .
Activator Deficiencies, Hexosaminidase .
Activator Deficiency, GM2 .
Activator Deficiency, Hexosaminidase .
Activator Deficient Tay Sachs Disease .
Activator-Deficient Tay-Sachs Diseases .
Deficiencies, GM2 Activator .
Deficiencies, Hexosaminidase Activator .
Deficiency, GM2 Activator .
Deficiency, Hexosaminidase Activator .
Disease, Activator-Deficient Tay-Sachs .
Diseases, Activator-Deficient Tay-Sachs .
GM2 Activator Deficiencies .
GM2 Gangliosidosis, AB Variant .
GM2-Gangliosidoses, AB Variant .
Hexosaminidase Activator Deficiencies .
Tay Sachs Disease, AB Variant .
Tay-Sachs Disease, Activator-Deficient .
Tay-Sachs Diseases, Activator-Deficient .
Variant GM2-Gangliosidoses, AB .
Variant GM2-Gangliosidosis, AB .
Gangliosidosis GM2, AB Variant .
Gangliosidosis GM2, Type AB .
GM2 Protein Activator Deficiency Disease .
0.75
01